A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624

Clinical trial NCT05378893 · COMPLETED

Trial details

NCT number: NCT05378893
Sponsor: Zhejiang Doer Biologics Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy, Obesity, Metabolically

Start date: 2022-06-22
Primary completion: 2024-10-10
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.